Glucocorticoids inhibit NF-κB and impair binding of AP-1, leading to a decrease in pro-inflammatory cytokine production, but administration of these drugs can detrimentally dampen the immune response to acute injury, making them oftentimes more harmful than useful to ALI/ARDS patients134. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.